外染色体DNA驱动的瘤基因剂量异质性促进MYCN扩大癌症患者快速适应治疗
Giulia Montuori1, Fengyu Tu2,3, Di Qin4,5
1Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Cancer discovery
|August 7, 2025
概括
外染色体DNA (ecDNA) 放大驱动癌症的演变和神经母细胞瘤的治疗耐药性. 针对具有低ecDNA的衰老细胞可以克服对MYCN向疗法的耐药性.
科学领域:
- 癌症生物学 癌症生物学
- 遗传学 遗传学 是一个
- 基因组学就是基因组学.
背景情况:
- 外染色体DNA (ecDNA) 放大有助于瘤的进化和治疗耐药性.
- 不对称的ecDNA线粒分离违反了遗传遗传原理,导致瘤基因剂量变化.
研究的目的:
- 研究ecDNA放大如何影响瘤进化和MYCN放大神经母细胞瘤的治疗疗效.
- 了解ecDNA拷贝数异质性驱动表型多样性和治疗敏感性的机制.
主要方法:
- 理论模型与单细胞ecDNA量化和表型分析的整合.
- 评估ecDNA拷贝数对癌症细胞系,异种移植和原发性神经母细胞瘤细胞命运的影响.
主要成果:
- ecDNA副本数异质性驱动表型多样性和治疗敏感性,与染色体放大不同.
- 外染色体基因剂量在治疗压力下提供了进化优势.
- 衰老细胞具有减少的ecDNA复制数被确定为治疗耐药性的来源.
结论:
- 对于治愈癌症的治疗方法来说,ecDNA动态是一个重大挑战.
- 针对ecDNA驱动的表型脆弱性提供了一种策略,以克服MYCN放大癌症的治疗耐药性.
- 有针对性的消除衰老细胞可能会改善神经母细胞瘤的治疗结果.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


